TRANSDERMAL HRT RELIEVING POSTMENOPAUSAL SYMPTOMS
NCT02033512
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
66
Enrollment
OTHER
Sponsor class
Conditions
Menopause
Interventions
DRUG:
Transdermal Hormone Replacement Therapy
DRUG:
Transdermal Nanoformulation
DRUG:
Transdermal formulation
Sponsor
University Potiguar
Collaborators
[object Object]